The elimination of racial bias in kidney function testing represents one of medicine's most concrete steps toward addressing health disparities that have persisted for decades. By correcting historical inequities in how kidney disease severity was measured, this policy change offers a measurable path to transplant equity that could serve as a model for other medical specialties grappling with embedded racial biases.
Analysis of 181,314 kidney transplant candidates revealed that when the Organ Procurement and Transplantation Network mandated wait time modifications for Black patients in January 2023, transplant rates increased significantly across multiple metrics. The policy addressed decades of race-based kidney function equations that systematically assigned higher estimated function to Black patients, artificially delaying their entry into transplant programs when their actual kidney disease was more advanced.
This represents a rare instance where medicine has quantifiably corrected a discriminatory practice and measured the health outcomes. The interrupted time series analysis spanning 2022-2025 demonstrates that policy-level interventions can rapidly translate into measurable clinical benefits when targeting specific, well-documented sources of bias. However, the study's quasi-experimental design means that concurrent healthcare changes could influence results, and the analysis period may be too brief to capture long-term transplant access patterns. The findings suggest that systematic review of race-based clinical algorithms across other medical domains could yield similar equity improvements, though each specialty will require careful evaluation of how racial adjustments affect patient care and outcomes.